Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) fair value: what the stock is really worth
We calculate from audited financials what Selcuk Ecza Deposu Ticaret ve Sanayi AS is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Selcuk Ecza Deposu Ticaret ve Sanayi AS for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
60‑month range 7.52 TRY – 400.00 TRY · fair‑value band 174.55 TRY – 494.14 TRY · the 291.75 TRY price screens above the 282.82 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Selçuk Ecza Deposu Ticaret ve Sanayi A.S., together with its subsidiary, operates as a pharmacy depot in Turkey. In addition, the company is involved in operation of pharmaceutical warehouses; and distributes cosmetics, personal care, infant food, vitamins, medical, and other products. The company was founded in 1958 and is based in Istanbul, Turkey.
Show more
Selçuk Ecza Deposu Ticaret ve Sanayi A.S., together with its subsidiary, operates as a pharmacy depot in Turkey. In addition, the company is involved in operation of pharmaceutical warehouses; and distributes cosmetics, personal care, infant food, vitamins, medical, and other products. The company was founded in 1958 and is based in Istanbul, Turkey. Selçuk Ecza Deposu Ticaret ve Sanayi A.S. is a subsidiary of Selçuk Ecza Holding A.S.
Stock analysis
Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) currently trades at 291.75 TRY, while our model-based Fair Value estimate is 282.82 TRY, implying the stock looks roughly 3.2% fairly valued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 222.69 TRY per share, and 1 of the 13 models we run sit above the 291.75 TRY price.
Bear case: the Asset-Based group reads lowest at 32.34 TRY, and 12 of the 13 models stay below the price. Evidence for this calculation is medium.
Scenario range: 174.55 TRY (bear) to 494.14 TRY (bull), the price of 291.75 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Selcuk Ecza Deposu Ticaret ve Sanayi AS reported revenue of 172B TRY in FY2025 versus 26.2B TRY in FY2021, a compound +60.0%/yr. Reported net income was −380M TRY in FY2025.
Key figures
Market cap 181B TRY (≈ $3.7B) · P/E ratio 156.0 · P/S ratio 0.76 · EPS (TTM) 1.87 TRY · Net margin −0.2% · Return on equity 3.8% · Return on assets (EBIT) 10.5% · Operating margin 5.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades near its 52-week high and 342% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −3%, SELEC screens cheaper than that median.
Fair Value models
Bear 174.55 TRYFair Value 282.82 TRYBull 494.14 TRY
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then (1.32 TRY per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.76/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+2.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+56.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+52.2%
Revenue growth 21 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
3.2% (2020) → 2.2% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+25.6%
Yearly growth needed for the next five years to justify today's price.
Compare Selcuk Ecza Deposu Ticaret ve Sanayi AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 80 stocks
Beats the industry median on 5/14 measures
Overall it trails its industry peers.
Valuation
Quality Score43 · Below median
Fair Value upside−52% · Bottom 25%
Profitability
Return on equity (TTM)4% · Below median
Return on assets3% · Above median
Net margin (TTM)1% · Below median
Operating margin (TTM)6% · Above median
Growth and dividend
Revenue growth6% · Above median
Dividend yield (TTM)0.0% · Bottom 25%
Valuation Multiplesvs Medical Distribution median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Selcuk Ecza Deposu Ticaret ve Sanayi AS Fair Value". https://www.fairvalue-calculator.com/stock/SELEC
Frequently asked questions
Is Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of 282.82 TRY versus a price of 291.75 TRY, about −3% upside (fairly valued).
What is the fair value of SELEC?
Our model-based fair value for Selcuk Ecza Deposu Ticaret ve Sanayi AS is 282.82 TRY (as of Sep 13, 2026), built from audited fundamentals. The current price: 291.75 TRY.
What is the quality score of SELEC?
Selcuk Ecza Deposu Ticaret ve Sanayi AS has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Our model-based price target is the fair value of 282.82 TRY (as of Sep 13, 2026) from 13 valuation models. Cautious scenario 174.55 TRY, optimistic scenario 494.14 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Selcuk Ecza Deposu Ticaret ve Sanayi AS stock forecast for 2026?
Our models put fair value at 282.82 TRY, about −3% upside versus a price of 291.75 TRY (fairly valued). Cautious scenario 174.55 TRY, optimistic scenario 494.14 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Selcuk Ecza Deposu Ticaret ve Sanayi AS reported trailing-twelve-month revenue of about 175B TRY (latest available figure, as of Sep 13, 2026).
What growth is priced into Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
For today's price to be fair in a discounted-cash-flow model, Selcuk Ecza Deposu Ticaret ve Sanayi AS would have to grow free cash flow by +25.6 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +52.3 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of SELEC use?
Our models discount Selcuk Ecza Deposu Ticaret ve Sanayi AS at 12.7 %: a base by market capitalisation (mid), damped by beta 0.18, country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Selcuk Ecza Deposu Ticaret ve Sanayi AS that is +25.6 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) delivered so far?
Over the past 5 years revenue at Selcuk Ecza Deposu Ticaret ve Sanayi AS grew +52.3 % a year. The price currently implies +25.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) growing?
The median revenue growth in the sector is +4.3 % a year. That is the yardstick for the growth priced into Selcuk Ecza Deposu Ticaret ve Sanayi AS (+25.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The free-cash-flow yield on the price is 3.17 %: that much free cash flow Selcuk Ecza Deposu Ticaret ve Sanayi AS produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Selcuk Ecza Deposu Ticaret ve Sanayi AS it is 282.82 TRY per share (as of Sep 13, 2026), against a price of 291.75 TRY. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is Selcuk Ecza Deposu Ticaret ve Sanayi AS stock overvalued or undervalued in 2026?
As of Sep 13, 2026, SELEC trades above its calculated fair value: price 291.75 TRY, fair value 282.82 TRY, a gap of about −3% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SELEC?
No. The price is what the market pays today (291.75 TRY); the fair value is what the company's own numbers justify (282.82 TRY). For Selcuk Ecza Deposu Ticaret ve Sanayi AS the two are 8.93 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Selcuk Ecza Deposu Ticaret ve Sanayi AS worth?
The market values Selcuk Ecza Deposu Ticaret ve Sanayi AS at about 181B TRY (market capitalisation, as of Sep 13, 2026). Per share that is 291.75 TRY; our models calculate a fair value of 282.82 TRY per share.
What do the bullish and bearish scenarios say about SELEC?
Our models span a range for Selcuk Ecza Deposu Ticaret ve Sanayi AS: cautious scenario 174.55 TRY, base 282.82 TRY, optimistic 494.14 TRY per share (as of Sep 13, 2026, price 291.75 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SELEC?
Selcuk Ecza Deposu Ticaret ve Sanayi AS trades at a price-to-earnings ratio of 156.0 (as of Sep 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 282.82 TRY is built from several models across several years. Other multiples: PEG 0.4, P/B 4.4, P/S 0.8, EV/EBITDA 24.9.
What is the PEG ratio of SELEC?
The PEG ratio of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 0.43 (P/E divided by earnings growth, as of Sep 13, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Balance-sheet figures for Selcuk Ecza Deposu Ticaret ve Sanayi AS (as of Sep 13, 2026): return on equity 3.8%. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is SELEC from its 52-week high?
Selcuk Ecza Deposu Ticaret ve Sanayi AS trades at 291.75 TRY, about 5% below its 52-week high of 278.00 TRY and 342% above the low of 66.02 TRY (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of 282.82 TRY is for.
Which stocks are comparable to Selcuk Ecza Deposu Ticaret ve Sanayi AS?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Selcuk Ecza Deposu Ticaret ve Sanayi AS stock attractive at the current price?
The data as of Sep 13, 2026: price 291.75 TRY, calculated fair value 282.82 TRY (−3%), Quality Score 43/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SELEC calculated?
We run Selcuk Ecza Deposu Ticaret ve Sanayi AS through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 282.82 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.6 % above its aggregate fair value. Selcuk Ecza Deposu Ticaret ve Sanayi AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The closing price on Sep 15, 2026 was 291.75 TRY. Our model-based fair value is 282.82 TRY, about −3% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Selcuk Ecza Deposu Ticaret ve Sanayi AS right now?
The model range is unusually wide (174.55 TRY to 494.14 TRY). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Key figures of Selcuk Ecza Deposu Ticaret ve Sanayi AS
How large is the market capitalisation of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The market capitalisation of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 181B TRY (≈ $3.7B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The price-to-sales ratio of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 0.76 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Earnings per share at Selcuk Ecza Deposu Ticaret ve Sanayi AS are 1.87 TRY (price ÷ EPS = P/E 156.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The net margin of Selcuk Ecza Deposu Ticaret ve Sanayi AS is −0.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The return on equity (ROE) of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 3.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
On an EBIT basis the return on assets of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 10.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
The operating margin of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 5.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Revenue at Selcuk Ecza Deposu Ticaret ve Sanayi AS is growing +5.8% versus a year earlier (3y avg +56.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC)?
Earnings per share at Selcuk Ecza Deposu Ticaret ve Sanayi AS are growing +550% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC) carry?
The net debt of Selcuk Ecza Deposu Ticaret ve Sanayi AS is 4.8B TRY (fiscal year 2024, ≈ 0.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Selcuk Ecza Deposu Ticaret ve Sanayi AS in the live analysis
One click puts Selcuk Ecza Deposu Ticaret ve Sanayi AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
